Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA COVID-19 booster response in rheumatology patients (COVER)
NCT05080218Phase 4Completed
- Sponsor
- Jeffrey Curtis
- Start
- Nov 2021
- Primary completion
- Apr 2024
- Modality
- Vaccines & Immunotherapeutics, Lipid-based Nanoparticles, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of mRNA COVID-19 vaccine in coronavirus disease 2019 (COVID-19), sponsored by Jeffrey Curtis. Started Nov 2021; status: completed.
02
Drugs
mRNA COVID-19 vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05080218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05080218.